Related expression of TRKA and P75 receptors and the changing copy number of<i>MYC</i>-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide
Alexander N. Chernov(Institute of Experimental Medicine), О. В. Шамова(St Petersburg University), Elisa Frullanti(University of Siena), Alessandra Renieri(University of Siena), Oleg S. Glotov(Research Institute of Obstetrics and Gynecology named after D.O. Ott), Diana Alaverdian(University of Siena), Sergei G. Shcherbak(City Hospital No. 40), Michael V. Talabaev(Republican Scientific and Practical Center of Neurology and Neurosurgery), Stanislav P. Urazov(City Hospital No. 40)
Cited by 1
Related Papers
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism
|Nature Genetics|2022|613
X-linked Alport Syndrome
|Journal of the American Society of Nephrology|2000|592
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins
|FEBS Letters|1993|515
X-Linked Alport Syndrome
|Journal of the American Society of Nephrology|2003|479
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?
|Frontiers in Cellular and Infection Microbiology|2019|278